Alessandra Borba Anton de Souza

8PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 16, 2025
Optimizing breast cancer therapy: chemoressitance and machine learning for precision prediction.

Martina Lichtenfels, Matheus G S Dalmolin, Julia Caroline Marcolin

|Mar 17, 2025
Oncological outcomes of breast-conserving surgery versus mastectomy following neoadjuvant chemotherapy in a contemporary multicenter cohort.

Francisco Pimentel Cavalcante, Felipe Pereira Zerwes, Ryane Alcantara

|Mar 07, 2025
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country.

Alessandra Borba Anton de Souza, Carlos Barrios, Rafaela Gomes de Jesus

|Nov 01, 2023
Low rate of complications in nipple-sparing mastectomy for patients with BRCA1 and BRCA2 mutation.

Antônio Luiz Frasson, Ana Beatriz Falcone, Fernanda Barbosa

|Nov 24, 2022
Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology.

Ruffo Freitas-Junior, Vilmar Marques de Oliveira, Antonio Luiz Frasson

|May 27, 2022
Nipple-sparing Mastectomy with Immediate Implant-based Reconstruction for Patients with Pure Ductal Carcinoma in Situ.

Antônio Luiz Frasson, Ana Beatriz Falcone, Isabela Miranda

Pageof 2